HOYA AI Stock Analysis
Want to see HOCPY full AI Analyst Report?
HOYA (HOCPY) AI Stock Analysis
HOYA
(Other OTC:HOCPY)
HOYA earns a high score on the strength of an outstanding financial profile: steady revenue compounding, expanding margins, a virtually debt-free balance sheet, return on equity near 28%, and cash flow that comfortably exceeds reported earnings. Technicals are supportive, with the price above all key moving averages and positive MACD momentum, though the short-term advance looks extended. The primary restraint is valuation — a P/E above 33 with only a 1.2% dividend yield leaves little margin for error, particularly as trailing revenue growth has slowed and results remain exposed to currency and semiconductor/eyewear cycles. With no earnings call commentary or corporate events available, the score rests on fundamentals, technicals and valuation.
HOYA (HOCPY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $48.85B
- Dividend Yield
- 1.38%
- Average Volume (3M)
- 32.60K
- Price to Earnings (P/E)
- 27.6
- Beta (1Y)
- 0.83
- Revenue Growth
- 7.04%
- EPS Growth
- 31.05%
- Country
- US
- Employees
- 37,752
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
HOYA Business Overview & Revenue Model
Company Description
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses...
How the Company Makes Money
HOYA makes money primarily by selling products and solutions across its major business lines, with revenue generally generated through a mix of high-volume consumables and higher-value equipment. 1) Vision Care (eyeglass lenses): HOYA generates reven...
HOYA Financial Statement Overview
Summary
Exceptional across all three statements. Revenue has compounded past ¥1 trillion with operating margins near 35% and net margins around 28%, while net income has grown faster than sales, evidencing real operating leverage. The balance sheet is effectively debt-free (debt-to-equity of 0.04) with equity funding about 78% of assets and return on equity near 28% achieved without leverage. Cash flow is equally strong: operating cash flow of roughly ¥304 billion covers net income about 1.5x, and free cash flow of roughly ¥246 billion converts about 81% of earnings. Offsets are modest — trailing revenue growth has decelerated to low single digits, reported gross margins swing widely between fiscal years, and results remain sensitive to currency and semiconductor/eyewear cycles.
Income Statement
91Very PositiveBalance Sheet
94Very PositiveCash Flow
90Very Positive| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 927.15B | 885.82B | 1.00T | 762.61B | 734.10B | 670.33B |
| Gross Profit | 765.40B | 766.25B | 793.79B | 421.69B | 631.86B | 567.28B |
| EBITDA | 451.54B | 310.00B | 359.07B | 285.70B | 259.78B | 243.96B |
| Net Income | 253.01B | 202.10B | 268.35B | 181.38B | 168.64B | 164.51B |
Balance Sheet | ||||||
| Total Assets | 1.31T | 1.23T | 1.31T | 1.20T | 1.03T | 992.84B |
| Cash, Cash Equivalents and Short-Term Investments | 580.98B | 538.53B | 576.58B | 525.16B | 426.27B | 426.63B |
| Total Debt | 41.46B | 37.28B | 42.42B | 29.24B | 24.58B | 21.60B |
| Total Liabilities | 264.40B | 262.65B | 267.05B | 241.36B | 213.72B | 203.78B |
| Stockholders Equity | 1.03T | 974.02B | 1.02T | 967.76B | 818.32B | 803.85B |
Cash Flow | ||||||
| Free Cash Flow | 153.05B | 187.19B | 235.25B | 181.73B | 168.36B | 161.18B |
| Operating Cash Flow | 194.99B | 235.11B | 295.24B | 222.80B | 201.83B | 190.06B |
| Investing Cash Flow | 8.07B | -33.19B | -8.04B | -35.81B | -47.50B | -29.30B |
| Financing Cash Flow | -214.81B | -190.35B | -277.01B | -110.89B | -194.59B | -106.72B |
HOYA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Negative. The current price of 144.18 is below the 20-day moving average (MA) of 154.64, below the 50-day MA of 153.86, and below the 200-day MA of 164.82, indicating a bearish trend. The MACD of -3.15 indicates Positive momentum. The RSI at 39.34 is Neutral, neither overbought nor oversold. The STOCH value of 45.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HOCPY.
HOYA Peers Comparison
Overall Rating
ISRG84Outperform
HOCPY82Outperform
BLCO65Neutral
BDX63Neutral
COO63Neutral
STAA59Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | $141.17B | 48.71 | 17.03% | ― | 20.45% | 8.75% | |
| 82Outperform | $49.43B | 27.62 | 27.70% | 1.38% | 7.04% | 31.05% | |
| 65Neutral | $7.40B | -66.81 | -1.73% | ― | 8.88% | 63.73% | |
| 63Neutral | $57.93B | 51.25 | 4.64% | 1.87% | -7.40% | -28.89% | |
| 63Neutral | $11.47B | 20.59 | 6.88% | ― | 4.73% | 43.89% | |
| 59Neutral | $1.26B | 2503.00 | 0.15% | ― | 42.36% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HOCPY | Hoya Corp | 144.18 | -3.21 | -2.18% | |
| BDX | Becton, Dickinson and Co | 212.78 | 66.38 | 45.34% | |
| COO | Cooper Companies | 58.88 | -17.13 | -22.54% | |
| ISRG | Intuitive Surgical | 399.05 | -169.43 | -29.80% | |
| STAA | Staar Surgical Company | 24.22 | -2.32 | -8.74% | |
| BLCO | Bausch + Lomb Corporation | 19.38 | 3.93 | 25.44% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 01, 2026
